Skip to main content
SpringerLink
Log in

Herbal Remedies

Issues in Licensing and Economic Evaluation

  • Current Opinion
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

In recent years, the use of alternative therapies has become widespread. In particular, there has been a resurgence in the public’s demand for herbal remedies, despite a lack of high-quality evidence to support the use of many of them. Given the increasing pressures to control healthcare spending in most countries, it is not surprising that attention is being focused on the cost effectiveness of herbal remedies.

We address the question of whether there is sufficient information to enable the assessment of the cost effectiveness of herbal remedies. In so doing, we discuss the current state of play with several of the more high-profile alternative herbal remedies [Chinese medicinal herbs for atopic eczema, evening primrose oil, ginkgo biloba, hypericum (St John’s wort)] and some which have made the transition from being alternative to being orthodox remedies. We use historical context to discuss, on the one hand, the increasing commodification of herbal remedies and on the other, the trend towards greater regulatory control and licensing of alternative herbal remedies. We argue that unless great care is exercised, these changes are not necessarily in the best interests of patients.

In order to identify cost-effective care, we need reliable information about the costs as well as the efficacy and safety of the treatments being assessed. For most alternative therapies, such data are not available.We believe that studies to gather such data are long overdue.Whilst we argue strongly in favour of control of some herbal remedies, we urge caution with the trend towards licensing of all herbal remedies. We argue that the licensing of those herbal remedies with equivocal benefits and few risks, as evidenced by a long history of safe use, increases barriers to entry and increases societal healthcare costs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Germany leads in branded phytomedicines [news report]. OTC Bull 1996; 14: 15

    Google Scholar 

  2. Ernst E. Over-the-counter complementary remedies used for arthritis. Pharm J 1998; 260: 830–1

    Google Scholar 

  3. Grünwald J, Büttel K. The European phytotherapeutics market: figures, trends, analyses. Drugs Germany 1996; 39: 6–11

    Google Scholar 

  4. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107–11

    Article  PubMed  CAS  Google Scholar 

  5. Phytopharm’s eczema herbs [news report]. Pharm J 1996; 257: 630

    Google Scholar 

  6. Grabowski HG, Vernon JM. Returns to research and development on new drug introductions in the 1980s. J Health Econ 1994; 13: 383–406

    Article  PubMed  CAS  Google Scholar 

  7. Brooks A. Viagra is licensed in Europe but rationed in Britain [news report]. BMJ 1998; 317: 765

    Article  PubMed  CAS  Google Scholar 

  8. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. London: The Pharmaceutical Press, 1996

    Google Scholar 

  9. Smith I. Commissioning complementary medicine. BMJ 1995; 310: 1151–2

    Article  PubMed  CAS  Google Scholar 

  10. Kleijnen J, de Craen AJM. The importance of the placebo effect: a proposal for further research. In: Ernst E, editor. Complementary medicine: an objective appraisal. Oxford: Butterworth-Heinemann, 1996

    Google Scholar 

  11. Oh VMS. The placebo effect: can we use it better? BMJ 1994; 309: 69–70

    Article  PubMed  CAS  Google Scholar 

  12. De Smet PAGM. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997; 54 (6): 801–40

    Article  PubMed  Google Scholar 

  13. Somberg J, Greenfield B, Tepper D. Digitalis: historical development in clinical medicine. J Clin Pharmacol 1985; 25: 484–9

    Article  PubMed  CAS  Google Scholar 

  14. Sheehan MP, Rustin MHA, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992; 340: 13–7

    Article  PubMed  CAS  Google Scholar 

  15. Withering W. An account of the Foxglove and some of it’s medical uses: practical remarks on dropsy and other diseases. Birmingham: M. Sweney, 1785

    Book  Google Scholar 

  16. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992; 126: 179–84

    Article  PubMed  CAS  Google Scholar 

  17. Sheehan MP, Atherton DJ. One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994; 130: 488–93

    Article  PubMed  CAS  Google Scholar 

  18. Sheehan MP, Stevens H, Ostlere LS, et al. Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol 1995; 20: 136–40

    Article  PubMed  CAS  Google Scholar 

  19. Perharic L, Shaw D, Leon C, et al. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet Hum Toxicol 1995; 37: 562–6

    PubMed  CAS  Google Scholar 

  20. Kleijnen J. Evening primrose oil: currently used in many conditions with little justification. BMJ 1994; 309: 824–5

    Article  PubMed  CAS  Google Scholar 

  21. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema: relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989; 121: 75–90

    Article  PubMed  CAS  Google Scholar 

  22. Berth-Jones J, Graham-Brown RAC. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341: 1557–60

    Article  PubMed  CAS  Google Scholar 

  23. Budeiri D, LiWan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996; 17: 60–8

    Article  PubMed  CAS  Google Scholar 

  24. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992; 340: 1136–9

    Article  CAS  Google Scholar 

  25. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997; 278: 1327–32

    Article  PubMed  CAS  Google Scholar 

  26. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775–6

    Article  PubMed  CAS  Google Scholar 

  27. De Smet PAGM, Nolan WA. St John’s wort as an antidepressant: longer term studies are needed before it can be recommended in major depression. BMJ 1996; 313: 241–2

    Article  PubMed  Google Scholar 

  28. Linde K, Ramirez G, Mulrow CD, et al. St John’s wort for depression: an overview and meta-analysis of randomized clinical trials. BMJ 1996; 313: 253–8

    Article  PubMed  CAS  Google Scholar 

  29. Guidelines on psychotropic drugs for the EC. Eur Neuropsychopharmacol 1994; 4: 61–77

    Article  Google Scholar 

  30. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215–8

    Article  PubMed  CAS  Google Scholar 

  31. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–4

    Article  PubMed  CAS  Google Scholar 

  32. Ernst E, editor. Complementary medicine: an objective appraisal. Oxford: Butterworth-Heinemann, 1996

    Google Scholar 

  33. Ernst E, De Smet PAGM. Risks associated with complementary therapies. In: Dukes MNG, editor. Meyler’s side effects of drugs. 13th ed. Amsterdam: Elsevier, 1996: 1427–54

    Google Scholar 

  34. D’Arcy PF. Adverse reactions and interactions with herbal medicines. Part 2: drug interactions. Adverse Drug React Toxicol Rev 1993; 12: 147–62

    PubMed  Google Scholar 

  35. Stricht BV, Parvais OE, Vanhaelen-FastrÚ RJ, et al. Remedies may contain cocktail of active drugs [letter]. BMJ 1994; 308: 1162

    Article  Google Scholar 

  36. Markowitz SB, Nunez CM, Klitzman S, et al. Lead poisoning due to Hai Ge Fen. JAMA 1994; 271: 932–4

    Article  PubMed  CAS  Google Scholar 

  37. Keane FM, Taylor NF, Higgins EM. Chinese herbal creams: the active component [abstract]. Br J Dermatol 1998; 139 Suppl. 51: 21

    Google Scholar 

  38. European Scientific Cooperative for Phytotherapy (ESCOP). Proposals for European monographs. Vols. 1–3. Meppel: ESCOP, 1990–1992

  39. Ernst E. Bitter pills of nature: safety issues in complementary medicine. Pain 1995; 60: 237–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Evidence-Based Pharmacotherapy, School of Health and Life Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, England

    Darren M. Ashcroft &  Alain Li Wan Po

Authors
  1. Darren M. Ashcroft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alain Li Wan Po
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alain Li Wan Po.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ashcroft, D.M., Li Wan Po, A. Herbal Remedies. Pharmacoeconomics 16, 321–328 (1999). https://doi.org/10.2165/00019053-199916040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199916040-00001

Keywords

Search

Navigation